AG
RPRX icon

AlTi Global’s Royalty Pharma RPRX Stock Holding History

AlTi Global’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,073
Closed -$1.2M – 526
2026
Q1 		$1.2M Sell
25,073
-25,554
-50% -$1.12M 0.03% 210
2025
Q4 		$1.96M Sell
50,627
-19,775
-28% -$754K 0.04% 162
2025
Q3 		$2.48M Sell
70,402
-19,544
-22% -$708K 0.06% 146
2025
Q2 		$3.24M Sell
89,946
-73,890
-45% -$2.45M 0.08% 125
2025
Q1 		$5.1M Sell
163,836
-223,731
-58% -$7.09M 0.13% 91
2024
Q4 		$9.89M Buy
+387,567
New +$10.3M 0.24% 51

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlTi Global's RPRX Position: Q2 2026 in Review

AlTi Global sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 25,073 shares — an estimated $1.2M sold.

AlTi Global first reported a position in RPRX in Q4 2024 and held it in 6 quarters. The position peaked at $9.89M in Q4 2024. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • AlTi Global reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • AlTi Global sold 25,073 Royalty Pharma shares in Q2 2026, an estimated $1.2M.
  • AlTi Global first reported a position in Royalty Pharma in Q4 2024 and held it in 6 quarters.
  • AlTi Global's Royalty Pharma position peaked at $9.89M in Q4 2024.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.